[SLRX] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
09-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- 16.97%
YoY- 63.27%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 571 1,243 165 246 -
PBT -1,424 -3,877 -4,718 -3,074 -1,784 -1,385 -9,052 -26.50%
Tax 0 -120 -38 -42 62 0 0 -
NP -1,424 -3,877 -4,718 -3,074 -1,784 -1,385 -9,052 -26.50%
Tax Rate - - - - - - - -
Total Cost 1,424 3,877 4,718 3,646 3,028 1,549 9,297 -26.83%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 -538.05 -143.51 -840.76 -3,687.09 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -2.37 -1.43 -2.20 -1.72 -3.20 -11.48 -313.66 -55.66%
EPS Diluted -2.37 -1.43 -2.20 -1.72 -3.20 -11.48 -313.66 -55.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.